ApicHope Pharmaceutical Group Co., Ltd. (SHE:300723)
China · Delayed Price · Currency is CNY 38.72
+0.23 (0.60%)
Aug 14, 2026, 3:04 PM CST
SHE:300723 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 940.78 | 932.27 | 1,450 | 2,503 | 2,280 | 2,199 |
Revenue Growth | -21.88% | -35.72% | -42.07% | 9.79% | 3.68% | 31.26% |
Gross Profit Gross Profit Growth | 540.08 | 515.51 | 874.02 | 2,021 | 1,980 | 1,877 |
Operating Income Operating Income Growth | -302.59 | -327.01 | -293.44 | 229.35 | 294.58 | 256.25 |
Net Income Net Income Growth | 199.99 | -337.79 | -540.04 | 184.61 | 290.68 | 306.92 |
Earnings Per Share EPS Growth | 0.44 | -0.75 | -1.20 | 0.41 | 0.67 | 0.72 |
EPS Growth | - | - | - | -39.18% | -7.09% | 39.10% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Pharmaceutical Manufacturing Pharmaceutical Manufacturing Growth | 896.98 | 1,404 | 2,484 | 2,219 | 2,015 |
Pharmaceutical Agents and Others Pharmaceutical Agents and Others Growth | 35.29 | 46.69 | 19.33 | 61.01 | 184.56 |
Total Total Growth | 932.27 | 1,450 | 2,503 | 2,280 | 2,199 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,401 | 515.38 | 473.72 | 463.96 | 717.78 | 1,090 |
Total Debt Total Debt Growth | 2,084 | 2,073 | 1,691 | 802.43 | 1,168 | 1,229 |
Net Cash (Debt) Net Cash Growth | -682.86 | -1,558 | -1,217 | -338.46 | -449.87 | -139.01 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1.51 | -3.45 | -2.69 | -0.75 | -1.04 | -0.33 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 26.38 | 46.01 | -550.42 | 458.05 | 475.53 | 438.1 |
Capital Expenditures CapEx Growth | -111.8 | -127.21 | -319.76 | -334.46 | -605.78 | -561.23 |
Free Cash Flow Free Cash Flow Growth | -85.41 | -81.19 | -870.18 | 123.59 | -130.25 | -123.13 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Gross Margin | 57.41% | 55.30% | 60.27% | 80.75% | 86.83% | 85.36% |
Operating Margin | -32.16% | -35.08% | -20.23% | 9.16% | 12.92% | 11.65% |
Pretax Margin | 17.34% | -39.63% | -44.52% | 9.75% | 14.32% | 16.50% |
Profit Margin | 21.26% | -36.23% | -37.24% | 7.37% | 12.75% | 13.96% |
FCF Margin | -9.08% | -8.71% | -60.00% | 4.94% | -5.71% | -5.60% |
| Fiscal Year | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Period Ending | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.210 | 0.133 | 0.133 |
Dividend Per Share Growth | 57.54% | 0% | 43.95% |
Dividend Yield | 0.71% | 0.59% | 0.57% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 87.46 | - | - | 72.55 | 34.04 | 33.23 |
Forward PE | 33.38 | 58.60 | 30.13 | 30.71 | 29.43 | 27.61 |
P/FCF Ratio | - | - | - | 108.38 | - | - |
PS Ratio | 18.46 | 16.16 | 5.28 | 5.35 | 4.34 | 4.64 |